Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.

Wiedemann GM, Aithal C, Kraechan A, Heise C, Cadilha BL, Zhang J, Duewell P, Ballotti R, Endres S, Bertolotto C, Kobold S.

Transl Oncol. 2018 Nov 28;12(2):350-360. doi: 10.1016/j.tranon.2018.10.014. [Epub ahead of print]

2.

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.

Bacher U, Shumilov E, Flach J, Porret N, Joncourt R, Wiedemann G, Fiedler M, Novak U, Amstutz U, Pabst T.

Blood Cancer J. 2018 Nov 12;8(11):113. doi: 10.1038/s41408-018-0148-6. Review.

3.

Host Cell Proteome of Physcomitrella patens Harbors Proteases and Protease Inhibitors under Bioproduction Conditions.

Hoernstein SNW, Fode B, Wiedemann G, Lang D, Niederkrüger H, Berg B, Schaaf A, Frischmuth T, Schlosser A, Decker EL, Reski R.

J Proteome Res. 2018 Nov 2;17(11):3749-3760. doi: 10.1021/acs.jproteome.8b00423. Epub 2018 Oct 4.

PMID:
30226384
4.

Quantifying insightful problem solving: a modified compound remote associates paradigm using lexical priming to parametrically modulate different sources of task difficulty.

Becker M, Wiedemann G, Kühn S.

Psychol Res. 2018 Jun 27. doi: 10.1007/s00426-018-1042-3. [Epub ahead of print]

PMID:
29951753
5.

Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia.

Bacher U, Porret N, Joncourt R, Sanz J, Aliu N, Wiedemann G, Jeker B, Banz Y, Pabst T.

Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14. No abstract available.

6.

Memory responses of innate lymphocytes and parallels with T cells.

Rapp M, Wiedemann GM, Sun JC.

Semin Immunopathol. 2018 Jul;40(4):343-355. doi: 10.1007/s00281-018-0686-9. Epub 2018 May 28. Review.

PMID:
29808388
7.

The single berberine bridge enzyme homolog of Physcomitrella patens is a cellobiose oxidase.

Toplak M, Wiedemann G, Ulićević J, Daniel B, Hoernstein SNW, Kothe J, Niederhauser J, Reski R, Winkler A, Macheroux P.

FEBS J. 2018 May;285(10):1923-1943. doi: 10.1111/febs.14458. Epub 2018 Apr 19.

8.

RecQ Helicases Function in Development, DNA Repair, and Gene Targeting in Physcomitrella patens.

Wiedemann G, van Gessel N, Köchl F, Hunn L, Schulze K, Maloukh L, Nogué F, Decker EL, Hartung F, Reski R.

Plant Cell. 2018 Mar;30(3):717-736. doi: 10.1105/tpc.17.00632. Epub 2018 Mar 7.

9.

Predictive Validity of the Brazilian Portuguese Version of the Family Questionnaire for Relapse in Patients With Schizophrenia.

Zanetti ACG, Ciol MA, Wiedemann G, de Azevedo-Marques JM, Dantas RAS, Gherardi-Donato ECDS, Vedana KGG, Galera SAF.

J Nurs Meas. 2017 Dec 1;25(3):559-572. doi: 10.1891/1061-3749.25.3.559.

PMID:
29268835
10.

Negative schemata about the self and others and paranoid ideation in at-risk states and those with persisting positive symptoms.

Müller H, de Millas W, Gaebel W, Herrlich J, Hasan A, Janssen B, Juckel G, Karow A, Kircher T, Kiszkenow-Bäker S, Klingberg S, Klosterkötter J, Krüger-Özgürdal S, Lambert M, Lautenschlager M, Maier W, Michel TM, Mehl S, Müller BW, Pützfeld V, Rausch F, Riedel M, Sartory G, Schneider F, Wagner M, Wiedemann G, Wittorf A, Wobrock T, Wölwer W, Zink M, Bechdolf A.

Early Interv Psychiatry. 2018 Dec;12(6):1157-1165. doi: 10.1111/eip.12433. Epub 2017 May 19.

PMID:
28524542
11.

A phenol-enriched cuticle is ancestral to lignin evolution in land plants.

Renault H, Alber A, Horst NA, Basilio Lopes A, Fich EA, Kriegshauser L, Wiedemann G, Ullmann P, Herrgott L, Erhardt M, Pineau E, Ehlting J, Schmitt M, Rose JK, Reski R, Werck-Reichhart D.

Nat Commun. 2017 Mar 8;8:14713. doi: 10.1038/ncomms14713.

12.

Strigolactone biosynthesis is evolutionarily conserved, regulated by phosphate starvation and contributes to resistance against phytopathogenic fungi in a moss, Physcomitrella patens.

Decker EL, Alder A, Hunn S, Ferguson J, Lehtonen MT, Scheler B, Kerres KL, Wiedemann G, Safavi-Rizi V, Nordzieke S, Balakrishna A, Baz L, Avalos J, Valkonen JPT, Reski R, Al-Babili S.

New Phytol. 2017 Oct;216(2):455-468. doi: 10.1111/nph.14506. Epub 2017 Mar 6.

13.

Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells.

Wiedemann GM, Knott MM, Vetter VK, Rapp M, Haubner S, Fesseler J, Kühnemuth B, Layritz P, Thaler R, Kruger S, Ormanns S, Mayr D, Endres S, Anz D.

Oncoimmunology. 2016 Apr 25;5(9):e1175794. eCollection 2016.

14.

A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice.

Wiedemann GM, Jacobi SJ, Chaloupka M, Krächan A, Hamm S, Strobl S, Baumgartner R, Rothenfusser S, Duewell P, Endres S, Kobold S.

Oncoimmunology. 2016 May 31;5(7):e1189051. doi: 10.1080/2162402X.2016.1189051. eCollection 2016 Jul.

15.

The Polycomb group protein CLF emerges as a specific tri-methylase of H3K27 regulating gene expression and development in Physcomitrella patens.

Pereman I, Mosquna A, Katz A, Wiedemann G, Lang D, Decker EL, Tamada Y, Ishikawa T, Nishiyama T, Hasebe M, Reski R, Ohad N.

Biochim Biophys Acta. 2016 Jul;1859(7):860-70. doi: 10.1016/j.bbagrm.2016.05.004. Epub 2016 May 11.

PMID:
27179444
16.

Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

Anz D, Rapp M, Eiber S, Koelzer VH, Thaler R, Haubner S, Knott M, Nagel S, Golic M, Wiedemann GM, Bauernfeind F, Wurzenberger C, Hornung V, Scholz C, Mayr D, Rothenfusser S, Endres S, Bourquin C.

Cancer Res. 2015 Nov 1;75(21):4483-93. doi: 10.1158/0008-5472.CAN-14-3499. Epub 2015 Oct 2.

17.

Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.

Decker EL, Wiedemann G, Reski R.

Methods Mol Biol. 2015;1321:213-24. doi: 10.1007/978-1-4939-2760-9_15.

PMID:
26082225
18.

DNA METHYLTRANSFERASE 1 is involved in (m)CG and (m)CCG DNA methylation and is essential for sporophyte development in Physcomitrella patens.

Yaari R, Noy-Malka C, Wiedemann G, Auerbach Gershovitz N, Reski R, Katz A, Ohad N.

Plant Mol Biol. 2015 Jul;88(4-5):387-400. doi: 10.1007/s11103-015-0328-8. Epub 2015 May 6.

PMID:
25944663
19.

Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.

Gartz J, Wiedemann G.

Drug Test Anal. 2015 Sep;7(9):853-7. doi: 10.1002/dta.1795. Epub 2015 Mar 31. No abstract available.

PMID:
25826697
20.

Design and characterization of a modular membrane protein anchor to functionalize the moss Physcomitrella patens with extracellular catalytic and/or binding activities.

Morath V, Truong DJ, Albrecht F, Polte I, Ciccone RA, Funke LF, Reichart L, Wolf CG, Brunner AD, Fischer K, Schneider PC, Brüggenthies JB, Fröhlich F, Wiedemann G, Reski R, Skerra A.

ACS Synth Biol. 2014 Dec 19;3(12):990-4. doi: 10.1021/sb5000302.

PMID:
25524107
21.

Modes of action of TLR7 agonists in cancer therapy.

Kobold S, Wiedemann G, Rothenfußer S, Endres S.

Immunotherapy. 2014;6(10):1085-95. doi: 10.2217/imt.14.75. Review.

PMID:
25428647
22.

Insights from the cold transcriptome of Physcomitrella patens: global specialization pattern of conserved transcriptional regulators and identification of orphan genes involved in cold acclimation.

Beike AK, Lang D, Zimmer AD, Wüst F, Trautmann D, Wiedemann G, Beyer P, Decker EL, Reski R.

New Phytol. 2015 Jan;205(2):869-81. doi: 10.1111/nph.13004. Epub 2014 Sep 10.

23.

Large-scale gene expression profiling data for the model moss Physcomitrella patens aid understanding of developmental progression, culture and stress conditions.

Hiss M, Laule O, Meskauskiene RM, Arif MA, Decker EL, Erxleben A, Frank W, Hanke ST, Lang D, Martin A, Neu C, Reski R, Richardt S, Schallenberg-Rüdinger M, Szövényi P, Tiko T, Wiedemann G, Wolf L, Zimmermann P, Rensing SA.

Plant J. 2014 Aug;79(3):530-9. doi: 10.1111/tpj.12572. Epub 2014 Jul 9.

24.

Why do bad things happen to me? Attributional style, depressed mood, and persecutory delusions in patients with schizophrenia.

Mehl S, Landsberg MW, Schmidt AC, Cabanis M, Bechdolf A, Herrlich J, Loos-Jankowiak S, Kircher T, Kiszkenow S, Klingberg S, Kommescher M, Moritz S, Müller BW, Sartory G, Wiedemann G, Wittorf A, Wölwer W, Wagner M.

Schizophr Bull. 2014 Nov;40(6):1338-46. doi: 10.1093/schbul/sbu040. Epub 2014 Apr 17.

25.

Investigation of decision-making under uncertainty in healthy subjects: a multi-centric fMRI study.

Krug A, Cabanis M, Pyka M, Pauly K, Walter H, Landsberg M, Shah NJ, Winterer G, Wölwer W, Musso F, Müller BW, Wiedemann G, Herrlich J, Schnell K, Vogeley K, Schilbach L, Langohr K, Rapp A, Klingberg S, Kircher T.

Behav Brain Res. 2014 Mar 15;261:89-96. doi: 10.1016/j.bbr.2013.12.013. Epub 2013 Dec 16.

PMID:
24355752
26.

Attenuated prefrontal activation during decision-making under uncertainty in schizophrenia: a multi-center fMRI study.

Krug A, Cabanis M, Pyka M, Pauly K, Kellermann T, Walter H, Wagner M, Landsberg M, Shah NJ, Winterer G, Wölwer W, Brinkmeyer J, Müller BW, Kärgel C, Wiedemann G, Herrlich J, Vogeley K, Schilbach L, Rapp A, Klingberg S, Kircher T.

Schizophr Res. 2014 Jan;152(1):176-83. doi: 10.1016/j.schres.2013.11.007. Epub 2013 Dec 8.

PMID:
24325976
27.

[Multiple-choice vocabulary intelligence test MWT in schizophrenia: valid measure of premorbid intelligence?].

Wittorf A, Wiedemann G, Klingberg S.

Psychiatr Prax. 2014 Mar;41(2):95-100. doi: 10.1055/s-0033-1349595. Epub 2013 Oct 2. German.

PMID:
24089322
28.

[Determinants of direct cost in schizophrenia patients with persistent positive symptoms].

Konnopka A, Stuhldreher N, Klingberg S, Wittorf A, Bechdolf A, Müller BW, Sartory G, Wagner M, Wiedemann G, Wölwer W, Heinrich S, König HH.

Psychiatr Prax. 2014 May;41(4):215-20. doi: 10.1055/s-0033-1349463. Epub 2013 Oct 2. German.

PMID:
24089318
29.

Associations between therapy skills and patient experiences of change processes in cognitive behavioral therapy for psychosis.

Wittorf A, Jakobi-Malterre UE, Beulen S, Bechdolf A, Müller BW, Sartory G, Wagner M, Wiedemann G, Wölwer W, Herrlich J, Klingberg S.

Psychiatry Res. 2013 Dec 30;210(3):702-9. doi: 10.1016/j.psychres.2013.08.011. Epub 2013 Aug 28.

PMID:
23992793
30.

The precuneus and the insula in self-attributional processes.

Cabanis M, Pyka M, Mehl S, Müller BW, Loos-Jankowiak S, Winterer G, Wölwer W, Musso F, Klingberg S, Rapp AM, Langohr K, Wiedemann G, Herrlich J, Walter H, Wagner M, Schnell K, Vogeley K, Kockler H, Shah NJ, Stöcker T, Thienel R, Pauly K, Krug A, Kircher T.

Cogn Affect Behav Neurosci. 2013 Jun;13(2):330-45. doi: 10.3758/s13415-012-0143-5.

PMID:
23297009
31.

[Biomarker screening for early detection of cancer].

Wiedemann GJ.

Dtsch Med Wochenschr. 2013 Jan;138(1-2):43-5. doi: 10.1055/s-0032-1327370. Epub 2012 Dec 18. Review. German.

PMID:
23250696
32.

Physcomitrella PpORS, basal to plant type III polyketide synthases in phylogenetic trees, is a very long chain 2'-oxoalkylresorcinol synthase.

Kim SY, Colpitts CC, Wiedemann G, Jepson C, Rahimi M, Rothwell JR, McInnes AD, Hasebe M, Reski R, Sterenberg BT, Suh DY.

J Biol Chem. 2013 Jan 25;288(4):2767-77. doi: 10.1074/jbc.M112.430686. Epub 2012 Dec 7.

33.

Cultural adaptation and psychometric properties of the family questionnaire in a Brazilian sample of relatives of schizophrenia outpatients.

Zanetti AC, Wiedemann G, Dantas RA, Hayashida M, de Azevedo-Marques JM, Galera SA.

J Clin Nurs. 2013 Jun;22(11-12):1521-30. doi: 10.1111/j.1365-2702.2012.04351.x. Epub 2012 Nov 8.

PMID:
23134331
34.

Implantable cardioverter defibrillator shocks are prospective predictors of anxiety.

Schulz SM, Massa C, Grzbiela A, Dengler W, Wiedemann G, Pauli P.

Heart Lung. 2013 Mar-Apr;42(2):105-11. doi: 10.1016/j.hrtlng.2012.08.006. Epub 2012 Oct 27.

PMID:
23110854
35.

Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer.

Decker T, Fischer G, Bücke W, Bücke P, Stotz F, Grüneberger A, Gropp-Meier M, Wiedemann G, Pfeiffer C, Peschel C, Götze K.

J Cancer Res Clin Oncol. 2012 Nov;138(11):1945-50. doi: 10.1007/s00432-012-1258-3. Epub 2012 Jul 4.

PMID:
22760213
36.

Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms study.

Klingberg S, Herrlich J, Wiedemann G, Wölwer W, Meisner C, Engel C, Jakobi-Malterre UE, Buchkremer G, Wittorf A.

J Nerv Ment Dis. 2012 Jul;200(7):569-76. doi: 10.1097/NMD.0b013e31825bfa1d.

PMID:
22759932
37.

PpASCL, a moss ortholog of anther-specific chalcone synthase-like enzymes, is a hydroxyalkylpyrone synthase involved in an evolutionarily conserved sporopollenin biosynthesis pathway.

Colpitts CC, Kim SS, Posehn SE, Jepson C, Kim SY, Wiedemann G, Reski R, Wee AG, Douglas CJ, Suh DY.

New Phytol. 2011 Dec;192(4):855-68. doi: 10.1111/j.1469-8137.2011.03858.x. Epub 2011 Aug 29.

38.

Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.

Klingberg S, Wölwer W, Engel C, Wittorf A, Herrlich J, Meisner C, Buchkremer G, Wiedemann G.

Schizophr Bull. 2011 Sep;37 Suppl 2:S98-110. doi: 10.1093/schbul/sbr073.

39.

[Early onset psychosis: rationale and concept of a cognitive-behavioral intervention].

Güttgemanns J, Büch A, Sevecke K, Döpfner M, Lehmkuhl G, Herrlich J, Müller K, Wiedemann G, Klingberg S, Bechdolf A.

Fortschr Neurol Psychiatr. 2011 Sep;79(9):524-30. doi: 10.1055/s-0031-1281615. Epub 2011 Aug 25. Review. German.

PMID:
21870313
40.

Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial.

Klingberg S, Wittorf A, Meisner C, Wölwer W, Wiedemann G, Herrlich J, Bechdolf A, Müller BW, Sartory G, Wagner M, Kircher T, König HH, Engel C, Buchkremer G.

Trials. 2010 Dec 29;11:123. doi: 10.1186/1745-6215-11-123.

41.

Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study.

Nikisch G, Baumann P, Oneda B, Kiessling B, Weisser H, Mathé AA, Yoshitake T, Kehr J, Wiedemann G, Eap CB.

J Psychopharmacol. 2011 Jul;25(7):896-907. doi: 10.1177/0269881110389208. Epub 2010 Dec 8.

PMID:
21148022
42.

Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.

Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.

J Clin Psychopharmacol. 2010 Oct;30(5):496-503. doi: 10.1097/JCP.0b013e3181f2288e.

PMID:
20814316
43.

Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?

Wittorf A, Jakobi UE, Bannert KK, Bechdolf A, Müller BW, Sartory G, Wagner M, Wiedemann G, Wölwer W, Herrlich J, Buchkremer G, Klingberg S.

J Nerv Ment Dis. 2010 Jul;198(7):478-85. doi: 10.1097/NMD.0b013e3181e4f526.

PMID:
20611050
44.

Quality and correlates of specific self-esteem at the beginning stabilisation phase of schizophrenia.

Wittorf A, Wiedemann G, Buchkremer G, Klingberg S.

Psychiatry Res. 2010 Sep 30;179(2):130-8. doi: 10.1016/j.psychres.2009.03.024. Epub 2010 May 16.

PMID:
20483167
45.

Targeted knock-out of a gene encoding sulfite reductase in the moss Physcomitrella patens affects gametophytic and sporophytic development.

Wiedemann G, Hermsen C, Melzer M, Büttner-Mainik A, Rennenberg H, Reski R, Kopriva S.

FEBS Lett. 2010 Jun 3;584(11):2271-8. doi: 10.1016/j.febslet.2010.03.034. Epub 2010 Mar 30.

46.

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.

Nikisch G, Baumann P, Kiessling B, Reinert M, Wiedemann G, Kehr J, Mathé AA, Piel M, Roesch F, Weisser H, Schneider P, Hertel A.

J Psychiatr Res. 2010 Sep;44(12):754-9. doi: 10.1016/j.jpsychires.2010.02.004. Epub 2010 Feb 21. Retraction in: J Psychiatr Res. 2012 Aug;46(8):1108.

PMID:
20176367
47.
48.

Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Klingberg S, Wittorf A, Herrlich J, Wiedemann G, Meisner C, Buchkremer G, Frommann N, Wölwer W.

Eur Arch Psychiatry Clin Neurosci. 2009 Nov;259 Suppl 2:S149-54. doi: 10.1007/s00406-009-0047-8.

PMID:
19876673
49.

Evaluation of a cognitive behaviourally oriented service for relapse prevention in schizophrenia.

Klingberg S, Wittorf A, Fischer A, Jakob-Deters K, Buchkremer G, Wiedemann G.

Acta Psychiatr Scand. 2010 May;121(5):340-50. doi: 10.1111/j.1600-0447.2009.01479.x. Epub 2009 Nov 5.

PMID:
19895624
50.

[Research into the feasibility of cognitive behavioural therapy in the treatment of psychotic disorders].

Klingberg S, Wittorf A, Bechdolf A, Herrlich J, Kircher T, König HH, Müller B, Sartory G, Wagner M, Wiedemann G, Wölwer W, Buchkremer G.

Psychother Psychosom Med Psychol. 2009 Mar-Apr;59(3-4):141-8. doi: 10.1055/s-0029-1202373. Epub 2009 Apr 6. Review. German.

PMID:
19350474

Supplemental Content

Loading ...
Support Center